Psyence develops natural psilocybin products for the treatment of psychological trauma and mental health disorders
Psyence has raised $438K in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2025.
Psyence's investors include Brandon Kerzner, Cantheon Capital.
Psyence is headquartered in Toronto, Canada.
Psyence develops natural psilocybin products for the treatment of psychological trauma and mental health disorders
Psyence is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Psyence — Funding & Investors." VCBacked, June 18, 2025, https://www.vcbacked.co/company/psyence. Accessed September 29, 2026.
VCBacked. (2025). Psyence — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/psyence
{{cite web |title=Psyence — Funding & Investors |url=https://www.vcbacked.co/company/psyence |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated